| __timestamp | Biogen Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2232342000 | 20140000 |
| Thursday, January 1, 2015 | 2113100000 | 37173000 |
| Friday, January 1, 2016 | 1947900000 | 48616000 |
| Sunday, January 1, 2017 | 1935500000 | 108488000 |
| Monday, January 1, 2018 | 2106300000 | 244622000 |
| Tuesday, January 1, 2019 | 2374700000 | 287000000 |
| Wednesday, January 1, 2020 | 2504500000 | 354000000 |
| Friday, January 1, 2021 | 2674300000 | 186000000 |
| Saturday, January 1, 2022 | 2403600000 | 151000000 |
| Sunday, January 1, 2023 | 2549700000 | 232600000 |
| Monday, January 1, 2024 | 2403700000 | 267474000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, understanding the financial strategies of industry leaders is crucial. Biogen Inc. and Ionis Pharmaceuticals, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Biogen's SG&A expenses have consistently been higher, peaking in 2021 with a 38% increase from 2014. In contrast, Ionis Pharmaceuticals, while starting with significantly lower expenses, saw a dramatic rise, particularly between 2016 and 2020, where expenses increased by over 600%. This divergence highlights Biogen's established market presence and Ionis's aggressive growth strategy. As the biotech sector evolves, these financial trends offer insights into each company's operational focus and market positioning.
Novo Nordisk A/S and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Biogen Inc. and BeiGene, Ltd.
Biogen Inc. vs CymaBay Therapeutics, Inc.: SG&A Expense Trends
Biogen Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Biogen Inc. and MannKind Corporation: SG&A Spending Patterns Compared
Biogen Inc. and Taro Pharmaceutical Industries Ltd.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Biogen Inc. vs Novavax, Inc.
Biogen Inc. and BioCryst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and Ionis Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.